European journal of gastroenterology & hepatology, vol.33, 2021 (Peer-Reviewed Journal)
Article / Article
European journal of gastroenterology & hepatology
Science Citation Index Expanded, Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
fibrosis, metabolic (dysfunction) associated fatty liver disease, nutrition, screening, TRANSIENT ELASTOGRAPHY, HEPATIC-FIBROSIS, NAFLD, FRUCTOSE
Background and aim There is still no approved pharmacotherapy for metabolic (dysfunction) associated fatty liver disease (MAFLD). Although dietary and lifestyle modifications for weight loss remain the mainstay for disease management, the association between macro- and micronutrients and fibrosis stage in patients with MAFLD remains unclear. This study was undertaken to address this issue.